EU Approves €90 Billion Ukraine Aid as Frozen Russian Asset Plan Stalls 
FDA Memo Raises Questions About Possible COVID-19 Vaccine Links to Rare Child Deaths 
U.S. Pressures ICC to Limit Authority as Washington Threatens New Sanctions 
Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial 
Asian Stocks Slide as AI Spending Fears and Global Central Bank Decisions Weigh on Markets 
Novo Nordisk Appoints Greg Miley to Lead Corporate Affairs Amid U.S. Drug Pricing Pressure 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
U.S. Lifts Sanctions on Brazilian Supreme Court Justice Amid Shift in Brazil Relations 
Oil Prices Steady in Asia but Headed for Weekly Loss on Supply Glut Concerns 
Bolivia Orders Pre-Trial Detention of Former President Luis Arce Over Embezzlement Probe 
Preservation Group Sues Trump Administration to Halt $300 Million White House Ballroom Project 
Trump Signs Executive Order to Boost AI Research in Childhood Cancer 
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown 
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute 
U.S. Stock Futures Slip After CPI-Fueled Rally as Markets Weigh Economic Uncertainty 
Johnson & Johnson offered $8.9 billion to settle years-old lawsuits claiming that its talcum powder products caused cancer.
The New Jersey-based pharmaceutical giant described their proposal, which still needs a bankruptcy court’s approval, as an equitable and efficient resolution to all claims arising from cosmetic talc litigation.
If approved by the bankruptcy court and a majority of the claimants, the $8.9 billion deal would rank alongside those reached by cigarette corporations and opioid producers as one of the largest product liability settlements ever in the US
Thousands of claims have been filed against J&J because of talcum powder that may have contained traces of asbestos and was linked to ovarian cancer.
The company has never acknowledged wrongdoing, but as of May 2020, it no longer sells its talc-based baby powder in the US and Canada.
The $8.9 billion would be paid to the tens of thousands of claimants over 25 years through a J&J subsidiary, LTL Management LLC, which was set up to address the claims and has filed for bankruptcy protection.
A previous settlement involving LTL was rejected by an appellate court.
